Abcg2型
ABCC1公司
PARP抑制剂
流出
聚ADP核糖聚合酶
药理学
生物
抗药性
化学
运输机
ATP结合盒运输机
聚合酶
生物化学
酶
基因
遗传学
作者
Qiu‐Xu Teng,Zi‐Ning Lei,Jing‐Quan Wang,Yuqi Yang,Zhuo‐Xun Wu,Nikita Acharekar,Wei Zhang,Sabesan Yoganathan,Yihang Pan,John N.D. Wurpel,Zhe‐Sheng Chen,Shuo Fang
标识
DOI:10.1016/j.drup.2023.101028
摘要
The overexpression of ABC transporters on cancer cell membranes is one of the most common causes of multidrug resistance (MDR). This study investigates the impact of ABCC1 and ABCG2 on the resistance to talazoparib (BMN-673), a potent poly (ADP-ribose) polymerase (PARP) inhibitor, in ovarian cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI